Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Liraglutide in Obese Children with Autism Spectrum Disorder
IRCT20240119060733N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in obesity and Autism Spectrum Disorder (ASD), sponsored by Mashhad University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
03
Conditions
obesityAutism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20240119060733N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240119060733N1.